Federal award
TERUMO BCT BIOTECHNOLOGIES, LLC
H9222216C0081
Contract
Obligated and Ceiling
- Obligated (net)
- $20,135,723.26
- Ceiling (potential value, not spending)
- $20,135,723.26
- Current value
- $20,135,723.26
- Gross positive obligations
- $24,135,723.46
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- TERUMO BCT BIOTECHNOLOGIES, LLC · UGCGFJ9K7VR7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- TERUMO CORPORATION · NV6JAG7QKED5
- Awarding agency
- Department of War · sub-agency 97ZS · office H92405
- Funding agency
- Department of War · sub-agency 97ZS
- Product or service (PSC)
- AZ13 · R&D- OTHER RESEARCH AND DEVELOPMENT (ADVANCED DEVELOPMENT)
- Industry (NAICS)
- 339112 · SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING
- PIID
- H9222216C0081
- Award type code
- D
- Actions
- 30 · Jun 1, 2016 to Jul 16, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History30
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 16, 2021 | FY2021 | P00029 | D | $0.00 | — |
| May 26, 2021 | FY2021 | P00028 | D | $0.00 | — |
| Apr 30, 2021 | FY2021 | P00027 | D | $0.00 | — |
| Mar 31, 2021 | FY2021 | P00026 | B | $1,065,413.06 | — |
| Dec 23, 2020 | FY2021 | P00025 | B | $0.00 | — |
| Aug 20, 2020 | FY2020 | P00024 | B | $0.00 | — |
| Apr 27, 2020 | FY2020 | P00023 | M | $0.00 | — |
| Dec 11, 2019 | FY2020 | P00022 | Y | $0.00 | — |
| Sep 12, 2019 | FY2019 | P00021 | B | $2,590,655.00 | — |
| May 28, 2019 | FY2019 | P00020 | B | $5,005,561.31 | — |
| Jan 23, 2019 | FY2019 | P00019 | C | $2,315,550.00 | — |
| Sep 25, 2018 | FY2018 | P00018 | C | $171,410.45 | — |
| Sep 17, 2018 | FY2018 | P00017 | C | $4,000,000.00 | — |
| Sep 17, 2018 | FY2018 | P00016 | C | −$4,000,000.00 | — |
| Sep 13, 2018 | FY2018 | P00015 | C | $4,150,000.00 | — |
| Jun 27, 2018 | FY2018 | P00014 | C | $250,000.00 | — |
| Jun 4, 2018 | FY2018 | P00013 | C | $225,000.00 | — |
| Apr 25, 2018 | FY2018 | P00012 | C | $225,000.00 | — |
| Jan 18, 2018 | FY2018 | P00011 | M | $0.00 | — |
| Jan 18, 2018 | FY2018 | P00010 | C | $1,100,000.00 | — |
| Sep 29, 2017 | FY2017 | P00009 | G | $637,174.24 | — |
| Aug 18, 2017 | FY2017 | P00008 | M | $0.00 | — |
| Jun 13, 2017 | FY2017 | P00007 | C | −$0.20 | — |
| Apr 19, 2017 | FY2017 | P00006 | C | $500,000.00 | — |
| Mar 24, 2017 | FY2017 | P00005 | M | $0.00 | — |
| Dec 14, 2016 | FY2017 | P00003 | M | $0.00 | — |
| Dec 14, 2016 | FY2017 | P00004 | M | $0.00 | — |
| Jul 29, 2016 | FY2016 | P00002 | M | $0.00 | — |
| Jun 22, 2016 | FY2016 | P00001 | M | $0.00 | — |
| Jun 1, 2016 | FY2016 | 0 | — | $1,899,959.40 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.